Streamlining the Development and Validation Process in Discovery to Phase I Clinical Development

Reto Ossola, Group Leader for Biomarket Research at Biognosys, joins Pharma IQ to discuss Phase I Clinical Development. He outlines where he sees the main challenges in biomarker development at the moment and discusses some key ways to address the cost-efficiency pressures. The interview also takes a look at partnerships - Reto offers some best practice tips on assessing and working with a CRO, together with a summary of the main challenges in selecting partners and ensuring a good working relationship when entering into Discovery Outsourcing and Collaborations. He also outlines some of the different types of partnerships that Biognosys has been involved in and what he thinks is the best approach. Finally, we look at the hype in the market about identification and validation of biomarkers - and discuss whether this is expected to provide benefit within Phase I trials. Reto Ossola will be presenting at the Innovation in Phase 1 Clinical Development Conference in Munich from 20th - 22nd September. For further details please visit www.phase1clinicaldevelopment.com, call freephone 0800 652 2363 or email enquire@iqpc.co.uk.